Justin S. Platt

Justin S. Platt is a partner at Goodwin. Justin’s practice focuses on life sciences, capital markets, and corporate matters. He specifically represents issuers and underwriters in initial public offerings, public and private offerings of equity and debt securities, and a variety of other corporate finance transactions. Justin also represents a number of publicly traded biotechnology companies and their boards of directors in ongoing SEC compliance, capital raising and corporate governance matters. 

Justin’s recent client representations include the following:

Capital Markets

• Represented the underwriters in connection with Hemab Therapeutics Holdings, Inc.’s $346.7 million initial public offering
• Represented Rapport Therapeutics, Inc. in its $174.4 million initial public offering and concurrent private placement
• Represented Metagenomi, Inc. in its $93.75 million initial public offering
• Represented Century Therapeutics, Inc. in its $242.7 million initial public offering*
• Represented Cognition Therapeutics, Inc. in its $45.2 million initial public offering and additional follow-on offerings*
• Represented Nektar Therapeutics in a series of public follow-on offerings totaling over $900 million
• Represented Kymera Therapeutics, Inc. in its $258 million public follow-on offering
• Represented Century Therapeutics, Inc. in its $60 million private placement
• Represented the underwriters in connection with $75 million public offering for Taysha Gene Therapies, Inc.
• Represented SWK Holdings Corporation in its inaugural registered underwritten debt offering of approximately $33 million in 9.00% senior notes due 2027
• Represented Tela Bio, Inc. in multiple underwritten follow-on offerings totaling approximately $145 million
• Represented underwriters in multiple equity offerings and at-the-market offerings for life science issuers*

Transactions for other Industries

• Represented Athene Holdings Ltd. in its $1.24 billion initial public offering, multiple follow-on equity offerings, and inaugural senior notes offering*
• Represented the initial purchasers in connection with a series of convertible senior notes offering for Bitdeer Technologies Group totaling approximately $1.175 billion
• Represented the sales agents in connection with the $1 billion ATM for Bitdeer Technologies Group
• Represented the initial purchasers in connection with WhiteFiber’s $230 million convertible senior notes offering 
• Represented Moelis & Company as placement agent in connection with CorMedix Inc.’s $150 million convertible senior notes offering
• Represented the underwriters in connection with multiple underwritten public offerings of stock or tangible equity units for VSE Corporation totaling over $1.6 billion

*Denotes experience prior to joining Goodwin